Gainers
- Soleno Therapeutics, Inc. SLNO shares jumped 318.5% to $18.54 after the company released top-line results from randomized withdrawal period of study C602 of DCCR for Prader-Willi Syndrome.
- Femasys Inc. FEMY surged 244% to $1.1410 after the company received FDA 510(k) clearance for FemaSeed, an infertility treatment designed to deliver sperm directly to where conception occurs in a woman's fallopian tube.
- Intercept Pharmaceuticals, Inc. ICPT shares gained 77.3% to $18.50. Alfasigma agreed to acquire Intercept Pharmaceuticals for $19.00 per share in cash.
- Immunovant, Inc. IMVT jumped 75.6% to $35.60 after the company announced initial IMVT-1402 Phase 1 SAD and 300 mg subcutaneous MAD results.
- Tharimmune Inc THAR shares gained 39.5% to $0.3090 after falling around 5% on Monday.
- Acasti Pharma Inc. ACST gained 27.1% to $2.2250. Acasti announced a $7.5 million private placement equity financing.
- Cano Health, Inc. CANO surged 24.2% to $0.3380. Cano Health said it sold substantially all of the assets associated with the operation of Cano Health's senior-focused primary care centers in Texas and Nevada to CenterWell Senior Primary Care.
- Bullfrog AI Holdings, Inc. BFRG gained 23.6% to $3.5499. Bullfrog AI announced data from its preclinical study investigating the anti-cancer activity of a novel prodrug of mebendazole for glioblastoma.
- Avalo Therapeutics, Inc. AVTX gained 21.9% to $0.1987 after jumping over 36% on Monday. Avalo Therapeutics reported the payoff of the remainder of its $35 million debt owed to Horizon Technology Finance.
- Adaptive Biotechnologies Corporation ADPT shares climbed 21.2% to $6.16. Adaptive recently announced the launch of Epic integration for clonoSEQ.
- Infobird Co., Ltd IFBD shares gained 19.7% to $0.1561. Infobird recently announced receipt of delinquency notification letter from the Nasdaq.
- ARS Pharmaceuticals, Inc. SPRY gained 18.8% to $4.28 after Director Rajeev Shah acquired a total of 2,700,000 shares an average price of $3.03 for roughly $8.18 million.
- Roivant Sciences Ltd. ROIV gained 17% to $11.94 after the company announced initial IMVT-1402 Phase 1 SAD and 300 mg subcutaneous MAD results.
- Verve Therapeutics, Inc. VERV rose 16.6% to $13.25. Verve Therapeutics to unveil interim data on VERVE-101 at the American Heart Association's Event.
- Pliant Therapeutics, Inc. PLRX gained 15% to $16.77 after the company announced bexotegrast met its primary and secondary endpoints in the Phase 2a liver fibrosis trial.
- Fisker Inc. FSR rose 14.2% to $6.06 after the company announced that deliveries are set to ramp up.
- Planet Green Holdings Corp. PLAG surged 14.1% to $0.6470.
- BYND Cannasoft Enterprises Inc. BCAN rose 13.2% to $1.01.
- Adaptive Biotechnologies Corporation ADPT gained 12.4% to $5.71.
- Acutus Medical, Inc. AFIB jumped 11.7% to $0.6601.
- Aclarion, Inc. ACON gained 11.4% to $0.39.
- Vera Therapeutics, Inc. VERA climbed 10.3% to $15.69 as HC Wainwright & Co maintained a Buy rating on the stock and raised its price target from $10 to $25.
- Blue Star Foods Corp. BSFC rose 8.6% to $0.2520 after dipping 20% on Monday.
- NightHawk Biosciences, Inc. NHWK gained 7.5% to $0.57.
- Precigen, Inc. PGEN rose 7.4% to $1.44.
Losers
- TransCode Therapeutics, Inc. RNAZ shares fell 68.7% to $0.7990 after the company priced its $8 million public offering of 15.7 million shares at $0.51 per share.
- Murphy Canyon Acquisition Corp. CDT fell 35.7% to $6.67 after dipping 38% on Monday.
- Davis Commodities Limited DTCK declined 33.2% to $3.15. The company recently priced its IPO at $4 per share.
- Molekule Group, Inc. MKUL fell 28.8% to $0.2064.
- Polished.com Inc. POL fell 25.2% to $0.0928 after surging 40% on Monday.
- United Natural Foods, Inc. UNFI fell 23.3% to $14.51 after the company reported mixed fourth-quarter financial results and issued guidance.
- MicroAlgo Inc. MLGO fell 19.2% to $2.43.
- Genetron Holdings Limited GTH fell 18.2% to $0.7201.
- Greenfire Resources Ltd. GFR declined 16.4% to $6.52.
- Novo Integrated Sciences, Inc. NVOS fell 14.9% to $0.2261.
- Ebix, Inc. EBIX dipped 12.8% to $10.36.
- New Pacific Metals Corp. NEWP declined 12.2% to $1.9487. New Pacific Metals announced CAD$35 million bought deal financing.
- Greenfire Resources Ltd. GFR fell 11.5% to $6.90.
- Biophytis S.A. BPTS fell 11.2% to $1.4099. Biophytis shares jumped over 72% on Monday after the company and Skyepharma announced a partnership agreement for the production of regulatory batches of Sarconeos (BIO101) for severe forms of Covid-19.
- Roadzen, Inc. RDZN fell 10.3% to $4.8135.
- Akili, Inc. AKLI declined 9.4% to $0.5130.
- FaZe Holdings Inc. FAZE shares fell 8.9% to $0.1749 after jumping 25% on Monday.
- MSP Recovery, Inc. LIFW shares fell 7.8% to $0.1867 after declining around 15% on Monday.
- TROOPS, Inc. TROO fell 6.4% to $3.8199.
- Sacks Parente Golf, Inc. SPGC fell 6.3% to $1.2750. The company recently posted a narrower second-quarter loss.
- TD SYNNEX Corporation SNX fell 5.2% to $96.64. TD Synnex reported a third-quarter revenue decline of 9.1% Y/Y to $13.96 billion, missing the consensus of $14.11 billion.
Now Read This: Ethereum Rises But Remains Below This Key Level; Maker Emerges As Top Gainer
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: NewsPenny StocksSmall CapIntraday UpdateMarketsMoversTrading IdeasMid-Day MoversTop Gainers
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in